Benepali® PEN Patient Satisfaction Survey
NCT03327454 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2018-10-23
Summary
The main aim of this study is to ascertain general satisfaction among participants with rheumatic diseases with day-to-day use of the Benepali® prefilled pen by means of a standardised participant questionnaire. In addition, it is to be investigated whether differences exist in general participant satisfaction between participant groups who have undergone various prior treatment and/or have previous experience with application systems (participants new to the use of biologics, participants changing over from a prefilled injection or changing over from another pre-filled pen) and between participants of the various indication groups. Furthermore, the participants are to evaluate various aspects of using the Benepali® pre-filled pen based on their personal experience, such as e.g. handling, user-friendliness and features of the Benepali® pre-filled pen, as well as the effectiveness of the training on injection with the Benepali® pre-filled pen, based on participant satisfaction with the training received with the training pen and the evaluation of the training material received.
Conditions
- Rheumatoid Arthritis
- Spondyloarthropathies
Interventions
- BIOLOGICAL
-
Benepali
Administered as specified in the treatment arm.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Director · Biogen
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-08-10
- Primary Completion
- 2018-06-21
- Completion
- 2018-06-21
Countries
- Germany
Study Locations
More Related Trials
-
Etanercept SFP in RA Patients
NCT00413452 ·Status: COMPLETED ·Phase: PHASE3
-
Biomarker Signature and Musculoskeletal Ultrasound Profile in Rheumatoid Arthritis Patients
NCT02476084 ·Status: COMPLETED
-
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists
NCT00293722 ·Status: COMPLETED
-
Study Comparing Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept
NCT00459706 ·Status: COMPLETED ·Phase: PHASE3
-
A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis
NCT00976599 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effects of Oral Prednisone in Patients With Rheumatoid Arthritis (MK0000-088)
NCT00746512 ·Status: COMPLETED ·Phase: PHASE1
-
Serum Biomarkers Analysis in Patients With AR Treated With Anti-TMF
NCT02804204 ·Status: UNKNOWN
-
Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients
NCT04428424 ·Status: COMPLETED
-
Study Evaluating Enbrel in Patients With Rheumatoid Arthritis
NCT00245934 ·Status: COMPLETED
-
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
NCT03414502 ·Status: RECRUITING ·Phase: PHASE3
-
Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (Etanercept) Auto-Injector Versus Enbrel® Pre-Filled Syringes
NCT00094341 ·Status: COMPLETED ·Phase: PHASE4
-
A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.
NCT02486302 ·Status: COMPLETED
-
Discontinuation of TNF-alpha Inhibitors in Patients With Spondyloarthritis
NCT00726804 ·Status: TERMINATED ·Phase: PHASE4
-
Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)
NCT01557322 ·Status: COMPLETED
-
TNFalfa Blocking Treatment of Spondylarthropathies
NCT00133315 ·Status: COMPLETED ·Phase: PHASE4
-
The Oxylipin Response as a New PrEdictive Biomarker of Patient Responsiveness to Biotherapy in Rheumatoid Arthritis (OPERA)
NCT05552105 ·Status: COMPLETED ·Phase: NA
-
A Study of the Safety and Pharmacokinetics of PRO283698 in Patients With Rheumatoid Arthritis
NCT00888745 ·Status: COMPLETED ·Phase: PHASE1
-
Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes
NCT01258738 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With DMARDs Versus DMARDs Alone in Patients With Rheumatoid Arthritis
NCT01787149 ·Status: UNKNOWN ·Phase: PHASE3
-
Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS).
NCT01577563 ·Status: COMPLETED
-
MRI Evaluation Assessing Synovitis to Address the Unmet Need for Reliable Endpoints in SLE
NCT03355482 ·Status: TERMINATED ·Phase: PHASE2
-
Drug Outcome Survey for Biological Treatments in Rheumatoid Arthritis: an Observational Study (Dose)
NCT00794118 ·Status: COMPLETED
-
Evaluation of TNFα Blockers Monotherapy in Early Rheumatoid Arthritis in France
NCT02927535 ·Status: COMPLETED
-
Evaluation of Spironolactone Efficacy in Patient with Rheumatoid Arthritis (RA)
NCT05092984 ·Status: RECRUITING ·Phase: PHASE3
-
Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis
NCT00913458 ·Status: COMPLETED ·Phase: PHASE4